Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Oxycodone/Acetaminophen Solution in Healthy Subjects
NCT02966860Phase 1Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Aug 2016
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of oxycodone and acetaminophen in pain, sponsored by Mallinckrodt Pharmaceuticals. Primary endpoints: Area under the concentration-time curve from time 0 to the last quantifiable sample at 24 hours, Observed maximum plasma concentration at 24 hours and 2 more. Started Aug 2016; status: completed.
02
Drugs
oxycodoneacetaminophen
03
Conditions
pain
Beyond the preview
Go deeper on NCT02966860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02966860.